SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-013981
Filing Date
2018-03-12
Accepted
2018-03-12 08:01:21
Documents
79
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tv486805_10k.htm 10-K 1125959
2 EXHIBIT 21.1 tv486805_ex21-1.htm EX-21.1 1418
3 EXHIBIT 23.1 tv486805_ex23-1.htm EX-23.1 2884
4 EXHIBIT 31.1 tv486805_ex31-1.htm EX-31.1 9602
5 EXHIBIT 31.2 tv486805_ex31-2.htm EX-31.2 9667
6 EXHIBIT 32.1 tv486805_ex32-1.htm EX-32.1 3488
7 EXHIBIT 32.2 tv486805_ex32-2.htm EX-32.2 3609
14 GRAPHIC tv486805_img1.jpg GRAPHIC 61247
  Complete submission text file 0001144204-18-013981.txt   5976260

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT lpcn-20171231.xml EX-101.INS 1338779
9 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20171231.xsd EX-101.SCH 42872
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20171231_cal.xml EX-101.CAL 42891
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20171231_def.xml EX-101.DEF 301021
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20171231_lab.xml EX-101.LAB 347918
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20171231_pre.xml EX-101.PRE 353368
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36357 | Film No.: 18682095
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences